Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CIS002: An Open-Label, Multi-Center, Extension Study of Cyclosporine Inhalation Solution in Subjects Previously Enrolled in the APT Study CIS001

NCT00938236 is registered in ClinicalTrials.gov with APT Pharmaceuticals, Inc. as lead sponsor.

NCT NCT00938236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00938236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CIS002: An Open-Label, Multi-Center, Extension Study of Cyclosporine Inhalation Solution in Subjects Previously Enrolled in the APT Study CIS001
Lead sponsor
APT Pharmaceuticals, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
December 31, 2009
Completion date
December 31, 2011
Enrollment
17 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

lung transplant